Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Our objective was to investigate the importance of malaria infection/disease during pregnancy and more particularly during the first trimester; we also looked at the maternal-foetal interactions and their influence on the subsequent child's response to malaria infections during the first year of life. This study was carried out !in the same population recruited for the IUGR study (NCT00642408).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institute of Tropical Medicine, Belgium
• Collaborators: Centre Muraz; Departments of Parasitology and Public Health, ITM, Antwerp, Belgium; Laboratoire National de Santé Publique, Ouagadougou, Burkina Faso
• Treatments: Chloroquine; Chloroquine diphosphate; Folic Acid; Iron; Micronutrients; Pyrimethamine; Trace Elements; Vitamin B Complex

Criteria

Inclusion Criteria:

• 15 to 44 years

• females

• living in the study area

Exclusion Criteria:

• planning to move outside the district within two years

• regularly using a contraceptive methods

• already pregnant at the start of the trial